Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | SCD | O00767 | 8/20 | 0.42 |
| ▸ | SCD5 | Q86SK9 | 6/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | PKM | P14618 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | TAS2R8 | Q9NYW2 | 5/20 | 0.39 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27460671 | 0.81 | — | — | |
| SCHEMBL14336874 | 0.75 | LMNA (0.52) | L3MBTL1LMNASMN1; SMN2MAPT | |
| SCHEMBL22957172 | 0.75 | SIGMAR1 (0.50) | L3MBTL1LMNAPKMNPSR1USP2 | |
| SCHEMBL27830169 | 0.74 | ACHE (0.57) | — | |
| SCHEMBL5544837 | 0.67 | ME3 (0.46) | L3MBTL1LMNAPKMMAPT | |
| SCHEMBL25170721 | 0.67 | MCHR1 (0.45) | LMNASMN1; SMN2MAPTHTT | |
| Trifluoroacetic Acid SCHEMBL30282920 | 0.67 | LMNA (0.45) | L3MBTL1SCDSCD5LMNAPKM | |
| SCHEMBL17010774 | 0.66 | DRD4 (0.42) | L3MBTL1LMNAPKMNPSR1USP2 | |
| SCHEMBL23459580 | 0.66 | NR1H4 (0.40) | L3MBTL1USP2SMN1; SMN2MAPTHTT | |
| SCHEMBL7247446 | 0.65 | L3MBTL1 (0.51) | L3MBTL1SCDSCD5LMNANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4539849-A1 | COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 | C4 Therapeutics, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| WO-2023244764-A1 | COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 | C4 THERAPEUTICS, INC. (US) | 2023-12-21 | — | — | WO | disclosed |
| WO-2023244764-A1 | COMPOUNDS FOR THE TARGETED DEGRADATION OF SMARCA2 | C4 THERAPEUTICS, INC. (US) | 2023-12-21 | — | — | WO | disclosed |